Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 30.42 |
| Open | 30.42 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 30.40 - 30.92 |
| 52-week range | 29.20 - 40.48 |
| Volume | |
| Avg. volume | 2,777,208 |
| Market cap | 197.575B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | 15.69 |
| EPS (TTM) | 1.97 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 1.35 (4.37%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 37.86 |
Insider MonkeyHalozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is [Perla] (ph), and I’ll be your conference operator today. […]
- Thomson Reuters StreetEvents
Q1 2024 Halozyme Therapeutics Inc Earnings Call
Q1 2024 Halozyme Therapeutics Inc Earnings Call
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
© 2024 Yahoo. All rights reserved.